Asston Pharmaceuticals Shareholding

Asston Pharmaceuticals Ltd Shareholding Pattern

The Asston Pharmaceuticals Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Asston Pharmaceuticals Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Asston Pharmaceuticals Ltd (NSE: , BSE: 544445) operates in the Distribution services sector and Medical distributors industry. Monitoring the Asston Pharmaceuticals Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Asston Pharmaceuticals Ltd Shareholding Pattern (Latest)

The latest Asston Pharmaceuticals Ltd shareholding for Mar 2026 is:

• Promoters: 50.66%
• FII: 1.91%
• DII: 0%
• Public: 47.42%
• Government: 0%

Promoter holding in Asston Pharmaceuticals Ltd remains stable, reflecting consistent long-term commitment.

Asston Pharmaceuticals Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Asston Pharmaceuticals Ltd.

• Mar 2026: 50.66%
• Sept 2025: 50.66%
• Jun 2025: 50.66%

Promoter stake remains largely stable, showing consistent ownership structure.

Asston Pharmaceuticals Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Asston Pharmaceuticals Ltd.

• Mar 2026: 1.91%
• Sept 2025: 6.04%
• Jun 2025: 9.70%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Asston Pharmaceuticals Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 0%
• Sept 2025: 0%
• Jun 2025: 4.08%

DII holdings remain stable, reflecting steady institutional participation.

Asston Pharmaceuticals Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 47.42%
• Sept 2025: 43.30%
• Jun 2025: 35.56%

Public participation in Asston Pharmaceuticals Ltd has increased, indicating rising retail investor interest.

Asston Pharmaceuticals Ltd Government Holding

Government holding in Asston Pharmaceuticals Ltd currently stands at 0%.

Asston Pharmaceuticals Ltd operates without significant government ownership.

Asston Pharmaceuticals Ltd Shareholding Analysis Summary

The Asston Pharmaceuticals Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Asston Pharmaceuticals Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Asston Pharmaceuticals Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.